Multiple Myeloma clinical trials in North Dakota

9 actively recruiting multiple myeloma trials at 5 sites across North Dakota.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in diff…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT03937635

Sites in North Dakota:

Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
Essentia Health - Jamestown Clinic — Jamestown, North Dakota

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of c…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT04566328

Sites in North Dakota:

Sanford Bismarck Medical Center — Bismarck, North Dakota
Sanford South University Medical Center — Fargo, North Dakota
Southpointe-Sanford Medical Center Fargo — Fargo, North Dakota
Sanford Medical Center Fargo — Fargo, North Dakota
Sanford Broadway Medical Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

This phase III trial compares three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed multiple myeloma in patients who are not receiving a stem cell transplant and are consid…

Sponsor: SWOG Cancer Research Network

NCT ID: NCT05561387

Sites in North Dakota:

Sanford Bismarck Medical Center — Bismarck, North Dakota
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
Sanford South University Medical Center — Fargo, North Dakota
Southpointe-Sanford Medical Center Fargo — Fargo, North Dakota
Sanford Medical Center Fargo — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer). This study is seeking participants who: * Are 18 years …

Sponsor: Pfizer

NCT ID: NCT06152575

Sites in North Dakota:

Sanford Fargo Medical Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE:…

Sponsor: American Society of Clinical Oncology

NCT ID: NCT02693535

Sites in North Dakota:

Sanford Health- Bismarck — Bismarck, North Dakota
Sanford Health- Fargo — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

This phase II trial compares iberdomide maintenance therapy to disease monitoring for improving survival in patients who have received idecabtagene vicleucel (a type of chimeric antigen receptor T-cell \[CAR-T\] therapy) for multiple myelo…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06179888

Sites in North Dakota:

Sanford Broadway Medical Center — Fargo, North Dakota
Sanford Roger Maris Cancer Center — Fargo, North Dakota

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (adv…

Sponsor: Mayo Clinic

NCT ID: NCT05969860

Sites in North Dakota:

Altru Cancer Center — Grand Forks, North Dakota

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in North Dakota:

Sanford Bismarck Medical Center — Bismarck, North Dakota
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
Sanford South University Medical Center — Fargo, North Dakota
Southpointe-Sanford Medical Center Fargo — Fargo, North Dakota
Sanford Medical Center Fargo — Fargo, North Dakota

View on ClinicalTrials.gov →

Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska

NCT ID: NCT02012699

Sites in North Dakota:

Essentia Health — Fargo, North Dakota
Trinity Hospital Cancer Care Center — Minot, North Dakota

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20